Microarrayed recombinant allergens for diagnosis of allergy.

Area of Science:

• Allergy diagnostics
• Immunotechnology
• Molecular biology

Background:

• Current diagnostic methods using allergen extracts identify sensitization but not specific disease-eliciting allergens.
• Recombinant DNA technology has expanded the availability of recombinant allergen molecules, covering key allergen sources.

Purpose of the Study:

• To develop novel multi-allergen tests for determining and monitoring complex sensitization profiles in allergic patients.
• To utilize microarray technology with recombinant allergens for single-assay diagnostics.

Main Methods:

• Coapplication of recombinant allergens and microarray technology.
• Development of multi-allergen tests using microarrayed recombinant allergen molecules.
• Serum analysis from allergic patients requiring minimal sample volume.

Main Results:

• Demonstrated the feasibility of using microarray technology for multi-allergen testing.
• Established a method to determine and monitor disease-eliciting allergen profiles in single tests.
• Showcased the use of minute serum amounts for comprehensive allergy testing.

Conclusions:

• Microarray-based allergy testing offers a wealth of diagnostic information.
• This approach can significantly improve the diagnosis, prevention, and treatment of allergic diseases.
• Enables precise identification and monitoring of complex allergen sensitization profiles.